Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Fields

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Advances in Biological Regulation|December 14, 2020
EditorialAlan P Fields
Advances in Enzyme Regulation|November 10, 2009
The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancerAlan P Fields, Verline Justilien
Current Protocols in Pharmacology|February 11, 2014
Utility and applications of orthotopic models of human non-small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeuticsVerline Justilien, Alan P Fields
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cellsVerline Justilien, Alan P Fields
Pharmacological Research|June 16, 2007
Protein kinase C iota: human oncogene, prognostic marker and therapeutic targetAlan P Fields, Roderick P Regala
Advances in Enzyme Regulation|January 3, 2008
Protein kinase C isozymes as therapeutic targets for treatment of human cancersAlan P Fields, Nicole R Murray
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2003
Protein kinase C in disease: cancerAlan P Fields, W Clay Gustafson
Advances in Biological Regulation|January 13, 2016
The chromosome 3q26 OncCassette: A multigenic driver of human cancerAlan P Fields, Verline Justilien, Nicole R Murray
Molecular Cancer Research : MCR|November 1, 2013
PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesisYin Wang, Kristen S Hill, Alan P Fields
Cancer Cell|October 12, 2016
SOX2 Determines Lineage Restriction: Modeling Lung Squamous Cell Carcinoma in the MouseNicole R Murray, Verline Justilien, Alan P Fields
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Advances in Biological Regulation|December 14, 2020
EditorialAlan P Fields
Advances in Enzyme Regulation|November 10, 2009
The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancerAlan P Fields, Verline Justilien
Current Protocols in Pharmacology|February 11, 2014
Utility and applications of orthotopic models of human non-small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeuticsVerline Justilien, Alan P Fields
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cellsVerline Justilien, Alan P Fields
Pharmacological Research|June 16, 2007
Protein kinase C iota: human oncogene, prognostic marker and therapeutic targetAlan P Fields, Roderick P Regala
Advances in Enzyme Regulation|January 3, 2008
Protein kinase C isozymes as therapeutic targets for treatment of human cancersAlan P Fields, Nicole R Murray
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2003
Protein kinase C in disease: cancerAlan P Fields, W Clay Gustafson
Advances in Biological Regulation|January 13, 2016
The chromosome 3q26 OncCassette: A multigenic driver of human cancerAlan P Fields, Verline Justilien, Nicole R Murray
Molecular Cancer Research : MCR|November 1, 2013
PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesisYin Wang, Kristen S Hill, Alan P Fields
Cancer Cell|October 12, 2016
SOX2 Determines Lineage Restriction: Modeling Lung Squamous Cell Carcinoma in the MouseNicole R Murray, Verline Justilien, Alan P Fields
Pageof 9